Recro Pharma Presents Phase III IV Meloxicam Clinical Safety and Opioid Use Data at PAINWeek® 2017
Sep 05, 2017 11:00 am UTC| Business
IV Meloxicam 30mg Demonstrates Statistically Significant Reductions in Opioid Consumption in Overall Study Population and Important Subpopulations, Including in Patients Following Major Orthopedic Surgery and Advanced Age,...
Sep 05, 2017 11:00 am UTC| Business
ALAMEDA, Calif., Sept. 05, 2017 -- OncoCyte Corporation (NYSE AMERICAN:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced that Michael G. Vicari has been appointed to the...
Sep 05, 2017 11:00 am UTC| Business
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Sept. 05, 2017 -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq:RWLK) today announced that Kevin Hershberger, Chief Financial Officer, will present at the 19th...
Akcea Expands Leadership Team in Preparation for First Commercial Launch
Sep 05, 2017 11:00 am UTC| Business
CAMBRIDGE, Mass., Sept. 05, 2017 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc. focused on developing and commercializing drugs to treat patients with serious cardiometabolic...
Sep 05, 2017 11:00 am UTC| Business
SAN MATEO, Calif., Sept. 05, 2017 -- Nlyte Software today announced the appointment of Enzo Greco as the company’s Chief Strategy Officer. In his new role, Greco will focus on new strategic product and market...
Sep 05, 2017 11:00 am UTC| Business
CHANDLER, Ariz., Sept. 05, 2017 -- A new 1.8V Serial Quad I/O™ SuperFlash® memory device is now available from Microchip Technology Inc. (NASDAQ:MCHP). The SST26WF064C, a low-voltage 64 megabit device, combines Dual...
ZIOPHARM to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
Sep 05, 2017 11:00 am UTC| Business
BOSTON, Sept. 05, 2017 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Rodman Renshaw 19th Annual Global Investment Conference in...